Skip to main content

Table 8 Cardiac findings focusing on functional CMR results

From: Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach

  MD Normal LV and RV function Impaired LV and/or RV function p value
N = 63 N = 31 N = 32
LV-EDVi, ml/m2 85 ± 30 73 ± 18 96 ± 35 0.003
LV-ESVi, ml/m2 41 ± 21 27 ± 9 54 ± 21 <0.0001
LV-mass, g/m2 60 ± 16 53 ± 11 66 ± 18 0.001
LV-EF, % 53 ± 12 63 ± 6 44 ± 9 NA
RV-EF, % 53 ± 9 58 ± 7 49 ± 9 NA
LV-EF <55 %, n (%) 29 (46) 0 (0) 29 (91) NA
RV-EF <45 %, n (%) 10 (16) 0 (0) 10 (31) NA
LGE presence, n (%) 48 (76) 17 (55) 31 (97) <0.0001
LGE extent, % 7 (1–17) 1 (0–6) 16 (8–32) <0.0001
Abnormal CMR, n (%) 49 (78) 17 (55) 32 (100) NA
  1. Bold text indicates a significant p-value of <0.05